Chronic inflammatory demyelinating polyneuropathy
H Köller, BC Kieseier, S Jander… - New England Journal of …, 2005 - Mass Medical Soc
It is important to recognize chronic inflammatory demyelinating polyneuropathy, which has
features in common with the acute variant of inflammatory demyelinating polyneuropathy …
features in common with the acute variant of inflammatory demyelinating polyneuropathy …
Advances in the diagnosis, pathogenesis and treatment of CIDP
MC Dalakas - Nature Reviews Neurology, 2011 - nature.com
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic
autoimmune neuropathy. Despite clinical challenges in diagnosis—owing in part to the …
autoimmune neuropathy. Despite clinical challenges in diagnosis—owing in part to the …
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy …
PYK Van den Bergh, PA van Doorn… - Journal of the …, 2021 - Wiley Online Library
To revise the 2010 consensus guideline on chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP). Seventeen disease experts, a patient representative, and …
polyradiculoneuropathy (CIDP). Seventeen disease experts, a patient representative, and …
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the …
Joint Task Force of the Efns and the … - Journal of the Peripheral …, 2010 - Wiley Online Library
A European Federation of Neurological Societies/Peripheral Nerve Society consensus
guideline on the definition, investigation, and treatment of multifocal motor neuropathy …
guideline on the definition, investigation, and treatment of multifocal motor neuropathy …
Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition
JM Vallat, C Sommer, L Magy - The Lancet Neurology, 2010 - thelancet.com
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic neuropathy
of supposed immune origin. Understanding of its pathophysiology has recently improved …
of supposed immune origin. Understanding of its pathophysiology has recently improved …
History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy
PJB Dyck, JA Tracy - Mayo Clinic Proceedings, 2018 - Elsevier
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is probably the best
recognized progressive immune-mediated peripheral neuropathy. It is characterized by a …
recognized progressive immune-mediated peripheral neuropathy. It is characterized by a …
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
M Mahdi‐Rogers, R Brassington… - Cochrane Database …, 2017 - cochranelibrary.com
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a
disease that causes progressive or relapsing and remitting weakness and numbness. It is …
disease that causes progressive or relapsing and remitting weakness and numbness. It is …
Chronic inflammatory demyelinating polyradiculoneuropathy—Diagnostic pitfalls and treatment approach
AM Stino, E Naddaf, PJ Dyck, PJB Dyck - Muscle & Nerve, 2021 - Wiley Online Library
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by
progressive weakness and sensory loss, often affecting patientsʼ ability to walk and perform …
progressive weakness and sensory loss, often affecting patientsʼ ability to walk and perform …
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study
RMC Trial Group - The Lancet Neurology, 2009 - Elsevier
BACKGROUND: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
responds to treatment with corticosteroids, intravenous immunoglobulin, and plasma …
responds to treatment with corticosteroids, intravenous immunoglobulin, and plasma …
Chronic inflammatory demyelinating polyneuropathy
MM Dimachkie, RJ Barohn - Current treatment options in neurology, 2013 - Springer
Opinion statement Chronic Inflammatory polyneuropathies are an important group of
neuromuscular disorders that present chronically and progress over more than 8 weeks …
neuromuscular disorders that present chronically and progress over more than 8 weeks …